In MF and Sézary syndrome (SS), the proportion of CD30-positive tumor cells ranges from approximately 12% to 23%, increasing to 48% to 55% following large-cell transformation in MF patients. The gene discussed is TNFRSF8; the disease is synovial sarcoma.